Branding Containment Immune Response Vaccination 
pharmaphorum
AUGUST 13, 2020
How the COVID-19 pandemic is forging pharmaceutical brands into better shape. Day by day it becomes clearer that some brands are coming through the pandemic in better shape than ever. These are the brands that have clearly demonstrated emotional intelligence, that have shown emotional empathy to their target audience.
The Pharma Data
AUGUST 15, 2021
Food and Drug Administration (FDA) has approved TICOVAC (tick-borne encephalitis (TBE) vaccine) for active immunization to prevent TBE in individuals 1 year of age and older. 1 TICOVAC is the only FDA-approved vaccine to help protect U.S. We are proud to deliver the first vaccine to help protect people in the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pfizer
OCTOBER 20, 2022
Advisory Committee on Immunization Practices Recommends Pfizer’s PREVNAR 20® for Adults Previously Vaccinated with PREVNAR 13®. Advisory Committee on Immunization Practices Recommends Pfizer’s PREVNAR 20® for Adults Previously Vaccinated with PREVNAR 13®. Thu, 10/20/2022 - 11:33. Thursday, October 20, 2022 - 11:50am.
The Pharma Data
JANUARY 22, 2021
22, 2021 — Not many people have had the opportunity to get the COVID-19 vaccine yet. But while you wait your turn, there are some steps you can take to give the vaccine — whichever brand you get — a boost when it’s available to you. This evidence is likely relevant to the COVID-19 vaccine, the researchers said.
XTalks
SEPTEMBER 14, 2020
“Vaccine Nationalism” Could Prove the Undoing of COVID-19 Containment. Tension is mounting as nations big and small jockey around industry to ensure they are first in line to access a vaccine, should one prove to be successful against COVID-19. Moderna’s COVID-19 Vaccine. The price of that prize is incalculable.
The Pharma Data
DECEMBER 20, 2020
GPS has previously been shown to invoke multi-epitope, broad cross-reactivity along the full-length of the WT1 protein, suggestive of epitope spreading, and immunologically mediated cancer cell destruction, which are hallmarks of an effective cancer vaccine. This press release contains forward-looking statements. Kenilworth, N.J.,
The Pharma Data
FEBRUARY 8, 2021
Vaccines up 14.6%, driven by record demand for differentiated influenza vaccines and continued growth of PPH. due to decreased sales of Cough & Cold related portfolio in Europe partially offset by Digestive Health brands. to €36,041 million, driven by Dupixent ® (€3,534 million, up 73,9%) and Vaccines. CHC down 3.0%
Expert insights. Personalized for you.
92 
Let's personalize your content